Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Onkologie
|
January 8, 2004
Statistical trial designs and clinical practice: are they compatible?
C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2005
Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
C J A Punt
Onkologie
|
December 11, 2002
Performing phase III clinical trials: never an easy task
C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
New options and old dilemmas in the treatment of patients with advanced colorectal cancer
C J A Punt
Nederlands Tijdschrift Voor Geneeskunde
|
July 14, 2005
[Chemotherapy of patients with colorectal carcinoma]
C J A Punt
The Netherlands Journal of Medicine
|
May 17, 2006
Treatment of liver metastases from colorectal cancer
J Tol, C J A Punt
Expert Opinion on Pharmacotherapy
|
May 10, 2016
Oral drugs in the treatment of metastatic colorectal cancer
J J M Kwakman, C J A Punt
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2002
Biological therapy of colorectal cancer
E M H A de Kleijn, C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer
C J A Punt, C D Blanke, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer
L Mol, M Koopman, P B Ottevanger, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Onkologie
|
January 8, 2004
Statistical trial designs and clinical practice: are they compatible?
C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2005
Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
C J A Punt
Onkologie
|
December 11, 2002
Performing phase III clinical trials: never an easy task
C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
New options and old dilemmas in the treatment of patients with advanced colorectal cancer
C J A Punt
Nederlands Tijdschrift Voor Geneeskunde
|
July 14, 2005
[Chemotherapy of patients with colorectal carcinoma]
C J A Punt
The Netherlands Journal of Medicine
|
May 17, 2006
Treatment of liver metastases from colorectal cancer
J Tol, C J A Punt
Expert Opinion on Pharmacotherapy
|
May 10, 2016
Oral drugs in the treatment of metastatic colorectal cancer
J J M Kwakman, C J A Punt
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2002
Biological therapy of colorectal cancer
E M H A de Kleijn, C J A Punt
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2002
Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer
C J A Punt, C D Blanke, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2009
A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer
L Mol, M Koopman, P B Ottevanger, et al.
Page
of 12